Related Experiment Video
Updated: Jun 12, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma
Lin Xu1,2, Arhanti Sadanand1, Evan W Neczypor3
1Department of Pediatrics, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Researchers identified 47 potential cancer-driving genes in neuroblastoma using a new algorithm. These oncogenes reveal new therapeutic targets and vulnerabilities in this common childhood cancer.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Neuroblastoma, a common pediatric cancer, presents challenges in identifying actionable oncogenic drivers.
- Targeting specific oncogenes is crucial for developing effective neuroblastoma therapies.
Purpose of the Study:
- To nominate novel, potentially targetable oncogenic drivers in neuroblastoma using an integrative bioinformatics approach.
- To validate identified oncogenes as therapeutic targets and assess their correlation with patient survival.
Main Methods:
- Applied the iExCN Bayesian algorithm for integrative analysis of expression and copy-number data from 195 neuroblastoma specimens.
- Utilized CRISPR/Cas9 screening and RNA knockdown to validate gene dependencies in neuroblastoma cell lines.
- Confirmed gene dependencies using DepMap data and analyzed survival trends in neuroblastoma patient cohorts.
Main Results:
- The iExCN algorithm identified 47 candidate oncogenes, including known drivers (ALK, MDMY, MYCN, XPO1) and novel candidates.
- CRISPR screening revealed cell line-specific and shared vulnerabilities associated with iExCN genes.
- DepMap analysis confirmed significant dependency scores for iExCN genes across multiple neuroblastoma cell lines.
- A trend toward worse survival was observed in patients with copy number gains in more iExCN genes.
Conclusions:
- The study uncovers multiple, potentially targetable oncogenic drivers in neuroblastoma.
- The iExCN algorithm demonstrates a powerful, generalizable approach for discovering disease genes and therapeutic targets in cancer.
- Findings provide a foundation for developing new targeted therapies for neuroblastoma.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
